Shim Chi Young, Park Sungha, Choi Eui-Young, Kang Seok-Min, Cha Bong-Soo, Ha Jong-Won, Rim Se-Joong, Lee Hyun-Chul, Chung Namsik
Cardiology Division, Yonsei Cardiovascular Center and Research Institute, Yonsei University College of Medicine, Seoul 120-752, Korea.
Metabolism. 2008 Apr;57(4):448-52. doi: 10.1016/j.metabol.2007.11.003.
The aim of this study was to address whether albuminuria could predict myocardial dysfunction in diabetic patients without overt heart disease. We studied 67 patients with normal left ventricular (LV) ejection fraction and no evidence of LV hypertrophy or coronary artery disease (47 patients with type 2 diabetes mellitus and hypertension and 20 patients with hypertension only). Diabetes patients were divided into 3 groups based on albuminuria status: group II = no albuminuria (n = 20, <30 mg/d), group III = microalbuminuria (n = 13, 30-300 mg/d), and group IV = macroalbuminuria (n = 14, >300 mg/d). Twenty patients with hypertension only served as a control group (group I). Conventional 2-dimensional and Doppler echocardiography was done. Peak strain, peak systolic strain rate (SR), and peak diastolic SR of 6 LV segments in the apical views were measured and averaged in each patient. Conventional 2-dimensional parameters such as LV ejection fraction; left atrium volume index; LV mass; deceleration time; and mitral early peak, mitral late peak, myocardial early peak diastolic, and myocardial peak systolic velocities were not different among the 4 groups. However, peak strains were significantly lower in group III (P = .002) and group IV (P < .001) than in group I; and the absolute value of peak systolic SR was lower in group III (P = .033) and group IV (P < .001) than in group I. Furthermore, the value of peak diastolic SR was lower in group IV than in group I (P = .014). In diabetic patients with albuminuria, Doppler strain and SR imaging detected subclinical LV systolic and diastolic dysfunction; and albuminuria was associated with myocardial dysfunction in diabetic patients without overt heart disease.
本研究的目的是探讨蛋白尿是否能够预测无明显心脏病的糖尿病患者的心肌功能障碍。我们研究了67例左心室(LV)射血分数正常且无LV肥厚或冠状动脉疾病证据的患者(47例2型糖尿病合并高血压患者和20例仅患有高血压的患者)。糖尿病患者根据蛋白尿状况分为3组:第二组 = 无蛋白尿(n = 20,<30 mg/d),第三组 = 微量蛋白尿(n = 13,30 - 300 mg/d),第四组 = 大量蛋白尿(n = 14,>300 mg/d)。20例仅患有高血压的患者作为对照组(第一组)。进行了传统的二维和多普勒超声心动图检查。测量并计算了每位患者心尖视图中6个LV节段的峰值应变、峰值收缩应变率(SR)和峰值舒张SR。4组之间的传统二维参数如LV射血分数、左心房容积指数、LV质量、减速时间以及二尖瓣早期峰值、二尖瓣晚期峰值、心肌早期舒张峰值和心肌收缩峰值速度并无差异。然而,第三组(P = .002)和第四组(P < .001)的峰值应变显著低于第一组;第三组(P = .033)和第四组(P < .001)的峰值收缩SR绝对值低于第一组。此外,第四组的峰值舒张SR值低于第一组(P = .014)。在有蛋白尿的糖尿病患者中,多普勒应变和SR成像检测到亚临床LV收缩和舒张功能障碍;并且蛋白尿与无明显心脏病的糖尿病患者的心肌功能障碍相关。